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Interaction of cytosolic apo-aspartate aminotransferase with AMP has been studied under equilibrium 
conditions; e.g., equilibrium dialysis and spectrophotometric titration. Results show that a 1 : 1 
stoichiometric complex AMP-apo-aspartate aminotransferase monomer is formed. The calculated 
dissociation constants with the two different experimental techniques are 40.4 x 10m6 M-’ and 31.4 x 
10m6 M-l, respectively. These findings substantiate a previous hypothesis of control of the reconstitution 
of cytosolic apo-aspartate aminotransferases exerted by AMP. 
AMP Aspartate aminotransferase Pyridoxal-5 ‘-phosphate 
1. INTRODUCTION 
Regulation of enzyme levels in cells may be by 
metabolic effecters acting on the reconstitution of 
a holoenzyme from its coenzyme and apoenzyme. 
In the case of aspartate aminotransferase, 
authors in [l] showed that phosphate and sulphate 
esters of oestrogens inhibit the reconstitution reac- 
tion, thus supporting hormonal control of the ac- 
tive enzyme level [2]. We have reported that 
nucleotides inhibit the rate of binding of 
pyridoxal-5 ’-phosphate to cytosolic aspartate 
aminotransferase [3]. The control of the 
reconstitution of aspartate aminotransferase by 
nucleotides eems to be of interest as it could con- 
stitute the basis for a malate-aspartate shuttle 
metabolic regulation system. 
Results we obtained [3], even if unambiguously 
pointing out the interference of 5 ’ -nucleotides on 
the reconstitution process, did not give any direct 
information on the nature of the interaction which 
can be gained only by equilibrium measurements. 
The interaction of AMP, which has been shown 
to be one of the most effective inhibitors of the 
reconstitution process [4], has been studied under 
Abbreviation: PLP, pyridoxal-5’-phosphate 
equilibrium conditions by equilibrium dialysis and 
absorption spectroscopy. 
2. EXPERIMENTAL 
2.1. Materials 
Cytosolic holo-aspartate aminotransferase (EC 
2.6.1.1) from pig heart (cu subform) was prepared 
essentially as in [5]. The pyridoxamine holoenzyme 
was obtained essentially as in [6]. Enzyme concen- 
tration was determined using ~??280 = 6.58 X 
lo4 M-l. cm-’ for the holoenzyme monomer. 
Pyridoxal-5 ’ -phosphate, cysteine sulphinate and 
adenosine-5 ’ -phosphate were obtained from 
Sigma (St Louis MO). Hz[~%]O~ (1.84 Ci/mol) 
and [14C]AMP (538 Ci/mol) were from 
Radiochemical Centre (Amersham). 
2.2. Preparation of the apoenzyme 
To 1.0 ml of the pyridoxamine form of the 
holoenzyme (lo-20 mg/ml) in 50 mM Tris-HCl 
(pH 8.0), 0.4 ml of 2 M sodium acetate (pH 4.8) 
and 1.5 ml of 4.4 M ammonium sulphate were 
added. After 1 h of incubation at room 
temperature, further 3.0 ml of the ammonium 
sulphate solution were added and the solution was 
then kept in the refrigerator overnight. The 
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precipitated protein was centrifuged, washed twice 
with the ammonium sulphate solution and dissolv- 
ed in the minimum amount of 100 mM NaHCO3 
(pH 8.0). Gel filtration was then performed on a 
Sephadex G-25 column (1.5 x 20 cm), equilibrated 
and eluted with 50 mM Tris-HCI (pH 8.0). 
At this stage the activity was about 5% of the in- 
itial one but if the above procedure was repeated 
the residual activity became less than 2%. The ac- 
tivity recovery upon addition of an excess of 
pyridoxal-5 ’-phosphate was close to 100%. 
Resolution with ammonium-[3’S]sulphate was 
performed after neutralization of Hz[~‘S]O~ with 
concentrated ammonia and dilution with 
(NH&S04 to have a 4.4 M solution (0.2 Ci/mol). 
2.3. Equilibrium dialysis 
Experiments were performed in micro-dialysis 
cells (0.6 ml total volume), kept under continuous 
rotation to minimize aspecific absorption, in a 
perspex jacketed cylinder connected to a water 
bath at 25°C. Dialysis membranes were obtained 
by cutting pieces of Visking tubes previously boiled 
for 30 min in 5% NazCO3 containing 50 mM 
EDTA. 
Apoenzyme (lo-50 x 10m6 M subunit) in 
50 mM in Tris-HCI (pH 8.0) was left to reach the 
equilibrium with the labelled ligand for 12 h. The 
amount of ligand bound was calculated per mole 
of apoenzyme subunit, the actual protein concen- 
tration being measured by Lowry’s method using 
the holo-enzyme as reference protein. 
The binding data were treated as in [7] in terms 
of ligand bound over total protein concentration 
(r) as a function of the free ligand concentration 
(CF): 
r/cF = - r/Ki + n/Ki 
where: 
Ki = the apparent dissociation constant of the 
AMP-apoenzyme complex; 
n = the number of binding sites/monomer. 
2.4. Spectrophotometric titration 
Experiments were performed at 25°C using a 
Cary model 118 spectrophotometer. The sample 
cell contained apoenzyme (lo-20 x 10m6 M 
subunit) and variable amounts of AMP in 50 mM 
Tris-HCI (pH 8.0). To the sample and the 
reference cell containing the same buffer, 
pyridoxal-5 ’ -phosphate (1 x 10m3 M solution in 
Tris-HCI, pH 8.0) was added stepwise. After at- 
taining the equilibrium, the increase of the absorb- 
ance at 362 nm was recorded. The coenzyme 
bound was evaluated by means of an E362 = 
8000 M-r. cm-‘. The concentration of the free 
coenzyme was determined by difference. Under 
these conditions binding of the coenzyme to the 
apoenzyme follows a Langmuir isotherm. Hence 
binding data can be plotted according to the 
saturation function: 
B = (PLP)fdK + (PLP)free 
or its linearized form. 
K’ is the apparent dissociation constant of the 
reconstituted holoprotein. It is dependent on the 
AMP concentration and on the dissociation con- 
stant, Ki, of the AMP-apoenzyme complex accor- 
ding to the relationship: 
K’ = Ka( 1 + (AMP)/Ki ) 
where: 
K, = K’ when (AMP) = 0, and it is dependent on 
the buffer medium used [8]. 
3. RESULTS 
3.1. Preparation of the apoenzyme 
Care was taken in the apoenzyme preparation to 
avoid the presence of specific anions which could 
interfere with the binding of the coenzyme and of 
the nucleotide to the apoenzyme. For this reason, 
any procedure using phosphate as resolving agent 
[I] was avoided because the apoenzyme was con- 
taminated by phosphate ions [9]. The resolution 
procedure, described in section 2, combines some 
features of reported methods [lO,ll]. The apoen- 
zyme obtained resulted free from the resolving 
anion as shown by the test made with 
ammonium-[35S]sulphate (fig. 1). 
3.2. Equilibrium dialysis 
The binding of AMP to the apoenzyme was 
studied by measuring the amount of [14C]AMP 
bound to the protein by equilibrium dialysis ex- 
periments. A typical Scatchard plot is reported in 
fig.2. Results (as an average of 5 different ex- 
periments) lead us to calculate a 1.02 f 0.05 ratio 
of nucleotide bound/protein subunit and a Ki = 
40.4 + 0.3 x 10m6 M. Thus a 1: 1 stoichiometry can 
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Fig. 1. Elution profile of an apoenzyme preparation 
performed in the presence of %O$- as described in 
the experimental section. Absorbance was recorded at 
280 nm (0). Radioactivity was assayed on lo-111 aliquots 
( n ). The radioactivity of the pooled protein fraction was 
assayed on 0.5 ml triplicate aliquots and resulted to be 
identical to the background. 
Fig.2. Scatchard plot of equilibrium dialysis experiments 
with IL4C]AMP and apo-aspartate aminotransferase 
(33.7. 10m6 M subunit) performed at 25°C in 50 mM 
Tris-HCl buffer; r is the molar ratio of AMP 
bound/enzyme subunit and Cr is the concentration of 
the free nucleotide. The experimental points were treated 
by the least square method to obtain the equation of the 
line. 
be demonstrated for the AMP-apo-aspartate 
aminotransferase interaction and a direct 
equilibrium constant has been derived. 
3.3. Spectrophotometric experiment 
The binding of pyridoxal-5 ’ -phosphate to apo- 
aspartate aminotransferase in the presence of 
AMP was followed spectrophotometrically by 
measuring the increase of the absorption at 362 nm 
due to the formation of the aldimine bond. It 
should be underlined that experiments were per- 
formed in Tris buffer although it is well known 
that Tris base forms an aldimine with 
pyridoxal-5 ’ -phosphate [ 121. Only in this condi- 
tion has it been possible to obtain a measurable 
PLP-apo-aspartate aminotransferase dissociation 
constant value as shown in the case of the 
reconstitution of L-serine dehydratase [8]. Satura- 
tion curves (fig.3) show that AMP competes with 
the coenzyme in forming the holoprotein species 
absorbing at 362 nm. The reconstitution process, 
also in the presence of AMP, seems to be due to a 
single site interaction and can be described by the 
Langmuir equation. Linear plots (fig.4) show that 
AMP is a competitive inhibitor for 
Fig.3. Titration of apo-aspartate aminotransferase 
(15. 10m6 M subunit) with PLP in the presence of 
different AMP concentrations: A = 0; w = 0.051 mM; 
l = 0.076 mM; o = 0.118 mM; A = 0.249 mM. All 
the experiments were performed at 25°C in 50 mM 
Tris-HCI buffer. 
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Fig.4. Linear plots of saturation curves of apo-aspartate 
aminotransferase with PLP in the presence of different 
AMP concentrations. Symbols were as described in the 
legend to fig.3. The insert shows the dependence of the 
apparent dissociation constants (K’, q ) on the 
concentration of AMP. 
pyridoxal-5’-phosphate. In fact, an identical max- 
imum value of the coenzyme bound is always 
observed independently of the AMP concentra- 
tion. From the linear plot it is possible to calculate 
the apparent dissociation constant K' for the 
PLP-apo-aspartate aminotransferase complex. A 
derived plot, shown in the insert of fig.4, gives Ki 
a value of 31.4 x 10e6 M, which is in good agree- 
ment with the value obtained by equilibrium 
dialysis. This experiment clearly shows that the 
nucleotide is a competitive inhibitor of the coen- 
zyme for the reconstitution reaction, suggesting 
that pyridoxal-5 ’-phosphate and AMP could share 
a common binding domain, 
4. DISCUSSION 
The results reported above support previous 
evidence on a specific interaction of AMP with 
apo-aspartate aminotransferase. It is worthwhile 
to recall that the values of the dissociation constant 
of the AMP-apo-aspartate aminotransferase com- 
plex found in two different equilibrium conditions, 
are in very good agreement with the value found by 
comparing the initial reconstitution rates (table 1). 
This validates a simple procedure for determining 
the extent of inhibition of the reconstitution reac- 
tion [13]. 
Table 1 
Dissociation constant values found for the AMP-apo- 
aspartate aminotransferase with different procedures 
Procedure Ki (M-l) 
(x 106) 
Comparison of the initial 
reconstitution rate? 
Equilibrium dialysis 
Competition to PLP binding 
a Fiore et al. [3] 
37 
40.4 
31.4 
Present data show that a 1: 1 (AMP-apo- 
aspartate aminotransferase monomer) complex is 
formed and that AMP competes with 
pyridoxal-5’-phosphate for the same binding site. 
Thus the results demonstrate a direct and specific 
interaction of AMP in the reconstitution process. 
The effect we have investigated in vitro might con- 
stitute the basis of a physiological interaction in 
vivo. 
It has been shown that pyridoxal-5 ‘-phosphate 
can act as an affinity label for nucleotide binding 
domains in several enzymes [14]. Present data are 
suggestive of the use of nucleotides for the recogni- 
tion of pyridoxal-5 ’ -phosphate binding site. A 
more detailed picture could arise by investigating 
such interaction with different pyridoxal-5’- 
phosphate-dependent enzymes. 
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